These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3148127)

  • 1. Topical mupirocin vs. systemic erythromycin treatment for pyoderma.
    McLinn S
    Pediatr Infect Dis J; 1988 Nov; 7(11):785-90. PubMed ID: 3148127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.
    Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J
    Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical antibiotic treatment of impetigo with mupirocin.
    Eells LD; Mertz PM; Piovanetti Y; Pekoe GM; Eaglstein WH
    Arch Dermatol; 1986 Nov; 122(11):1273-6. PubMed ID: 3096221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo.
    McLinn S
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):883-5. PubMed ID: 2112166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin.
    Barton LL; Friedman AD; Sharkey AM; Schneller DJ; Swierkosz EM
    Pediatr Dermatol; 1989 Jun; 6(2):134-8. PubMed ID: 2501775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral amoxicillin vs. oral erythromycin in the treatment of pyoderma in Bamako, Mali: an open randomized trial.
    Faye O; Hay RJ; Diawara I; Mahé A
    Int J Dermatol; 2007 Oct; 46 Suppl 2():19-22. PubMed ID: 17958625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo.
    Goldfarb J; Crenshaw D; O'Horo J; Lemon E; Blumer JL
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1780-3. PubMed ID: 3149884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mupirocin: a topical antibiotic with a unique structure and mechanism of action.
    Parenti MA; Hatfield SM; Leyden JJ
    Clin Pharm; 1987 Oct; 6(10):761-70. PubMed ID: 3146455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of erythromycin versus mupirocin for the treatment of impetigo in children.
    Rice TD; Duggan AK; DeAngelis C
    Pediatrics; 1992 Feb; 89(2):210-4. PubMed ID: 1734386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections--an open multicentre trial.
    Bork K; Brauers J; Kresken M
    Br J Clin Pract; 1989 Aug; 43(8):284-8. PubMed ID: 2516463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impetigo.
    Esterly NB; Nelson DB; Dunne WM
    Am J Dis Child; 1991 Feb; 145(2):125-6. PubMed ID: 1899777
    [No Abstract]   [Full Text] [Related]  

  • 12. Pyoderma pathophysiology and management.
    Leyden JJ
    Arch Dermatol; 1988 May; 124(5):753-5. PubMed ID: 3129996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice.
    Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P
    Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
    Gisby J; Bryant J
    Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of cefadroxil and cephalexin in children and adolescents with pyodermas. Cefadroxil Once Daily Pyoderma Study Group.
    Linder CW; Nelson K; Paryani S; Stallworth JR; Blumer JL
    Clin Ther; 1993; 15(1):46-56. PubMed ID: 8458054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mupirocin: a new topical antibiotic.
    Leyden JJ
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):879-83. PubMed ID: 2112165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical antibiotics in dermatology.
    Hirschmann JV
    Arch Dermatol; 1988 Nov; 124(11):1691-700. PubMed ID: 2972259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of mupirocin (pseudomonic acid) in the treatment of pyoderma in children.
    Phillips LM; Yogev R; Esterly NB
    Pediatr Emerg Care; 1985 Dec; 1(4):180-3. PubMed ID: 3939498
    [No Abstract]   [Full Text] [Related]  

  • 19. Mupirocin in the treatment of impetigo. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1990 Mar; 142(6):543-4. PubMed ID: 2107019
    [No Abstract]   [Full Text] [Related]  

  • 20. Mupirocin (2 percent) ointment in the treatment of primary and secondary skin infections.
    Odom RB
    Cutis; 1989 Jun; 43(6):599-601. PubMed ID: 2501071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.